Skip to main content
. 2020 Jan 29;26(4):189–195. doi: 10.4103/meajo.MEAJO_208_19

Table 1.

Characteristics of the study sample

Characteristics (n) Percentage or mean±SD
Gender
 Male (99) 45.8
 Female (117) 54.2
Age (216) 12.8±2.8
Duration (216) 4.5±3.3
Weight (kg) (215) 57.5±25.7
Height (cm) (216) 150.9±24.6
BMI (kg/m2) (178) 22.7±5.6
DM
 Type 1 (194) 94.9
 Type 2 (17) 7.9
 Secondary DM (2) 0.9
 MODY (2) 0.9
 Worfram’s syndrome (1) 0.5
Comorbidities
 No comorbidities (205) 94.9
 DLP (7) 3.2
 HTN (2) 0.9
 Multiple (2) 0.9
Complications
 No complications (200) 92.6
 Microvascular (other than retinopathy) (16) 7.4
DKA at presentation
 No (143) 66.2
 Yes (73) 33.8
HbA1c (214) 10.0±2.3
RBS mmol/l (26) 13.5±6.7
ACR mg/mmol (192) 8.1±47.5
Lipid profile (153)
 Total cholesterol 4.7±1.0
 HDL mmol/l 1.4±0.3
 LDL mmol/l 2.9±0.9
 TG mmol/l 1.4±0.8
First DR screening
 Yes (113) 52.3
 No (103) 47.7
BCVA worse eye
 Normal (193) 90.2
 Abnormal (21) 9.8
IOP (mmHg)
 Normal (59) 85.5
 High IOP (10) 14.5
OCT RE (28)
 Average thickness (μm) 265.7±11.6
 Average volume (mm3) 7.5±0.3
Retinal treatment
 No treatment (216) 100

SD: Standard deviations, BMI: Body mass index, DM: Diabetes mellitus, MODY: Maturity-onset diabetes of the young, DLP: Dyslipidemia, HTN: Hypertension, DKA: Diabetic ketoacidosis, HbA1c: Glycated hemoglobin, RBS: Random blood sugar, ACR: Albumin/creatinine ratio, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, TG: Triglycerides, DR: Diabetic retinopathy, BCVA: Best-corrected visual acuity, IOP: Intraocular pressure, OCT: Optical coherence tomography

HHS Vulnerability Disclosure